Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects
- 1 August 1995
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 80 (8) , 2495-2498
- https://doi.org/10.1210/jc.80.8.2495
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: